TFAM and type 2 diabetes mellitus: In addition, The AMPK/PGC-1α/TFAM pathway was effectively inhibited by Compound C, supporting the hypothesis that EA may exert its effects on skeletal muscle glucose metabolism in T2DM via this axis.